Website Header with Language Selector and Dropdowns

Doxorubicin Hydrochloride
CAT No: CL-DXRN-01 CAS No: 25316-40-9 Mol Wt: 543.5 : 36.5 Mol F: C27H29NO11 : HCl Inv Status: In Stock
Chemical Name: (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Doxorubicin EP Impurity A
CAT No: CL-DXRN-02 CAS No: 23541-50-6 Mol Wt: 527.5 : 36.5 Mol F: C27H29NO10 : HCl Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-a-l-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
Doxorubicin EP Impurity B
CAT No: CL-DXRN-03 CAS No: 106401-68-7 Mol Wt: 652.5 Mol F: C29H34BrNO11 Inv Status: In Stock
Chemical Name: (8S,10S)-10[(3-Amino-2,3,6-trideoxy-a-l-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-dimethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Doxorubicin EP Impurity C
CAT No: CL-DXRN-04 CAS No: 65026-79-1 Mol Wt: 606.4 Mol F: C27H28BrNO10 Inv Status: In Stock
Chemical Name: (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-bromoacetyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Doxorubicin EP Impurity D
CAT No: CL-DXRN-05 CAS No: 24385-10-2 Mol Wt: 414.4 Mol F: C21H18O9 Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-6,8,10,11-Tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione ; doxorubicin aglycone ; doxorubicinone
Doxorubicin Mixture Of Diastereomers
CAT No: CL-DXRN-06 CAS No: 28008-55-1 Mol Wt: 529.5 Mol F: C27H31NO10 Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-((S)-1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Doxorubicin Dimer Impurity 1
CAT No: CL-DXRN-07 CAS No: 2755741-04-7 Mol Wt: 1069.1 Mol F: C54H56N2O21 Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)glycyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Doxorubicin Impurity 13
CAT No: CL-DXRN-08 CAS No: NA Mol Wt: 559.5 Mol F: C27H29NO12 Inv Status: Custom Synthesis
Chemical Name: (8R,10S)-10-((4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,7,8,11-tetrahydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Doxorubicin Impurity-Ll
CAT No: CL-DXRN-09 CAS No: 64845-67-6 Mol Wt: 336.3 Mol F: C19H12O6 Inv Status: Custom Synthesis
Chemical Name: 6,8,11-Trihydroxy-1-methoxytetracene-5,12-dione
Doxorubicin Impurity 17
CAT No: CL-DXRN-10 CAS No: 131086-18-5 Mol Wt: 680.5 Mol F: C31H38BrNO11 Inv Status: In Stock
Chemical Name: (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-bromo-1,1-diethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
9-Carboxy Doxorubicin Impurity
CAT No: CL-DXRN-12 CAS No: 58199-96-5 Mol Wt: 529.5 : 36.5 Mol F: C26H27NO11 : HCl Inv Status: Custom Synthesis
Chemical Name: (2S,4S)-4-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-2-carboxylic acid hydrochloride
Doxorubicin Impurity 15 (Mixture of Diastereomers) (TFA Salt)
CAT No: CL-DXRN-13 CAS No: NA Mol Wt: 529.5 : 114.0 Mol F: C27H31NO10 : C2HF3O2 Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione 2,2,2-trifluoroacetate
7,8-Desacetyl-9,10-dehydro Daunorubicinone
CAT No: CL-DXRN-14 CAS No: 1159977-24-8 Mol Wt: 352.3 Mol F: C19H12O7 Inv Status: Custom Synthesis
Chemical Name: 6,8,10,11-Tetrahydroxy-1-methoxytetracene-5,12-dione
9-Carboxy Doxorubicin Impurity 2
CAT No: CL-DXRN-15 CAS No: NA Mol Wt: 513.5 Mol F: C26H27NO10 Inv Status: Custom Synthesis
Chemical Name: (4S)-4-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5,12-dihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-2-carboxylic acid
Bis-Anhydro-Daunomycinone Carboxylic Acid
CAT No: CL-DXRN-16 CAS No: NA Mol Wt: 364.3 Mol F: C20H12O7 Inv Status: Custom Synthesis
Chemical Name: 5,12-Dihydroxy-7-methoxy-6,11-dioxo-6,11-dihydrotetracene-2-carboxylic acid
Desmethyl Doxorubicin
CAT No: CL-DXRN-17 CAS No: NA Mol Wt: 529.5 : 90.0 Mol F: C26H27NO11 : C2H2O4 Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-10-(((2R,4S,5S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,6,8,11-tetrahydroxy-8-(2-hydroxyacetyl)-7,8,9,10-tetrahydrotetracene-5,12-dione oxalate
Doxorubicin
CAT No: CL-DXRN-18 CAS No: 23214-92-8 Mol Wt: 543.5 Mol F: C27H29NO11 Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Doxorubicin Dimer Impurity 2
CAT No: CL-DXRN-19 CAS No: NA Mol Wt: 858.9 Mol F: C44H46N2O16 Inv Status: Custom Synthesis
Chemical Name: 2-(4-(((4R,5R)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5,8-dihydroxy-3,4-dihydronaphthalen-2-yl)-2-oxoethyl (4S)-4-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5,12-dihydroxy-7-methoxy-6,11-dioxo-3,4,6,11-tetrahydrotetracene-2-carboxylate
Doxorubicin Dimer Impurity 3
CAT No: CL-DXRN-20 CAS No: NA Mol Wt: 1087.1 Mol F: C54H58N2O22 Inv Status: Custom Synthesis
Chemical Name: (8S,8'S,10S,10'S)-8,8'-(4-Hydroxy-2-(hydroxymethyl)-1,3-dioxolane-2,4-diyl)bis(10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione)
Doxorubicin Impurity 16
CAT No: CL-DXRN-21 CAS No: NA Mol Wt: 559.5 Mol F: C27H29NO12 Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2,2-dihydroxyacetyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Doxorubicin Impurity 18
CAT No: CL-DXRN-22 CAS No: NA Mol Wt: 559.5 Mol F: C27H29NO12 Inv Status: Custom Synthesis
Chemical Name: (8R,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,7,8,11-tetrahydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Doxorubicin Impurity 19
CAT No: CL-DXRN-23 CAS No: 201278-93-5 Mol Wt: 1067 Mol F: C54H54N2O21 Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-((Z)-2-(((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)imino)acetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Doxorubicin Impurity 24
CAT No: CL-DXRN-24 CAS No: 80996-23-2 Mol Wt: 525.5 Mol F: C27H27NO10 Inv Status: Custom Synthesis
Chemical Name: (S)-7-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,11-dihydroxy-9-(2-hydroxyacetyl)-4-methoxy-7,8-dihydrotetracene-5,12-dione
Doxorubicin Impurity 25
CAT No: CL-DXRN-25 CAS No: NA Mol Wt: 364.3 Mol F: C20H12O7 Inv Status: Custom Synthesis
Chemical Name: Methyl 5,7,12-trihydroxy-6,11-dioxo-6,11-dihydrotetracene-2-carboxylate
Doxorubicin Impurity 26
CAT No: CL-DXRN-26 CAS No: NA Mol Wt: 364.3 Mol F: C20H12O7 Inv Status: Custom Synthesis
Chemical Name: 1,6,11-Trihydroxy-8-(2-hydroxyacetyl)tetracene-5,12-dione
Doxorubicin Impurity 27
CAT No: CL-DXRN-27 CAS No: 105612-58-6 Mol Wt: 378.3 Mol F: C21H14O7 Inv Status: Custom Synthesis
Chemical Name: 6,11-Dihydroxy-8-(2-hydroxyacetyl)-1-methoxytetracene-5,12-dione
Doxorubicin Impurity 28
CAT No: CL-DXRN-28 CAS No: 80948-70-5 Mol Wt: 396.4 Mol F: C21H16O8 Inv Status: Custom Synthesis
Chemical Name: (S)-6,7,11-Trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-7,8-dihydrotetracene-5,12-dione
Doxorubicin Impurity 29
CAT No: CL-DXRN-29 CAS No: NA Mol Wt: 394.3 Mol F: C21H14O8 Inv Status: Custom Synthesis
Chemical Name: 6,10,11-Trihydroxy-8-(2-hydroxyacetyl)-1-methoxytetracene-5,12-dione
Doxorubicin Olefin Impurity
CAT No: CL-DXRN-30 CAS No: NA Mol Wt: 511.5 Mol F: C26H25NO10 Inv Status: Custom Synthesis
Chemical Name: 4-(((2S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5,12-dihydroxy-7-methoxy-6,11-dioxo-3,4,6,11-tetrahydrotetracene-2-carboxylic acid
Doxorubicinolone (Mixture of Diastereomers)
CAT No: CL-DXRN-31 CAS No: 210837-88-0 Mol Wt: 416.4 Mol F: C21H20O9 Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-8-(1,2-Dihydroxyethyl)-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione
Esorubicin Hydrochloride
CAT No: CL-DXRN-32 CAS No: 63950-06-1 Mol Wt: 527.5 : 36.5 Mol F: C27H29NO10 : HCl Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-10-(((2S,4R,6S)-4-Amino-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
3'-Epi-Doxorubicin Hydrochloride
CAT No: CL-DXRN-33 CAS No: 67463-65-4 Mol Wt: 543.5 : 36.5 Mol F: C27H29NO11 : HCl Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-10-(((2R,4R,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
Doxorubicin Impurity 30
CAT No: CL-DXRN-34 CAS No: NA Mol Wt: 338.3 Mol F: C19H14O6 Inv Status: Custom Synthesis
Chemical Name: 6,8,11-Trihydroxy-1-methoxy-7,10-dihydrotetracene-5,12-dione
Doxorubicin 13CD3 TFA
CAT No: CL-DXRN-35 CAS No: NA Mol Wt: 547.5 : 114.0 Mol F: C2613CH26D3NO11 : C2HF3O2 Inv Status: Custom Synthesis
Chemical Name: (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-(methoxy-13C-d3)-7,8,9,10-tetrahydrotetracene-5,12-dione 2,2,2-trifluoroacetate
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.